Skip to main content

Table 2 Individual clinical factors and the risk of CAC progression

From: Different associations of atherogenic index of plasma, triglyceride glucose index, and hemoglobin A1C levels with the risk of coronary artery calcification progression according to established diabetes

 

CAC progression

Overall

Non-diabetes

Diabetes

OR (95% CI)

P

OR (95% CI)

P

OR (95% CI)

P

Age (per-1 year increase)

1.09 (1.08 − 1.09)

< 0.001

1.09 (1.08 − 1.10)

< 0.001

1.05 (1.04 − 1.06)

< 0.001

Male sex

2.50 (2.19 − 2.86)

< 0.001

2.57 (2.22 − 2.98)

< 0.001

1.78 (1.28 − 2.48)

0.001

Hypertension

2.60 (2.38 − 2.84)

< 0.001

2.66 (2.41 − 2.94)

< 0.001

1.35 (1.09 − 1.66)

0.005

Hyperlipidemia

1.68 (1.54 − 1.83)

< 0.001

1.72 (1.56 − 1.89)

< 0.001

1.02 (0.83 − 1.25)

0.839

Obesity

1.55 (1.43 − 1.68)

< 0.001

1.54 (1.41 − 1.69)

< 0.001

1.25 (1.02 − 1.53)

0.031

Current smoking

1.06 (0.96 − 1.16)

0.260

1.10 (0.99 − 1.22)

0.079

0.89 (0.63 − 1.08)

0.059

AIP (per-0.1 unit increase)

1.08 (1.07 − 1.10)

< 0.001

1.08 (1.07 − 1.10)

< 0.001

1.03 (1.00 − 1.07)

0.073

TyG index (per-1 unit increase)

1.73 (1.61 − 1.86)

< 0.001

1.63 (1.50 − 1.76)

< 0.001

1.20 (1.02 − 1.41)

0.031

HbA1C (per-1% increase)

1.51 (1.42 − 1.60)

< 0.001

1.42 (1.24 − 1.61)

< 0.001

1.13 (1.03 − 1.23)

0.008

Baseline CACS (per-10 unit increase)

1.03 (1.03 − 1.04)

< 0.001

1.04 (1.03 − 1.04)

< 0.001

1.01 (1.01 − 1.02)

< 0.001

  1. Analysis was adjusted for interscan periods
  2. AIP atherogenic index of plasma, CAC coronary artery calcification, CACS coronary artery calcium score, CI confidence interval, HbA1C hemoglobin A1C, OR odds ratio, TyG triglyceride glucose